
-
Club World Cup marks 'new era' for football: Infantino
-
Koepka gets Oakmont scolding and leaps into US Open title hunt
-
Trump warns Israeli attack on Iran 'could very well happen'
-
Club World Cup a chance for MLS to shine: Giroud
-
UN General Assembly calls for Gaza ceasefire, pressure on Israel
-
'Suck it up' - SGA says fatigue can't be a factor in NBA Finals
-
Bolivia police officer blown up by pro-Morales demonstrators: govt
-
Frank faces pressure to make instant impact at Spurs
-
Im grabs share of US Open lead as Pavon attacks, Scheffler struggles
-
BTS fans gather for K-pop supergroup's annual celebration
-
Northern Ireland hit by fourth night of clashes
-
Thunderstorms may rain on Trump's military parade
-
Manhandling of US senator ups California tensions with Trump admin
-
Spaun takes US Open nervous energy to record Oakmont start
-
Race ban would be his own fault, Russell warns Verstappen
-
Double bogey confidence boost helps Lawrence shine at Open
-
Bolt beams as Alfred, Duplantis and Warholm light up Oslo Diamond League
-
Hamilton slams Italian media speculation on Ferrari and Vasseur
-
Warholm sets world best in 300m hurdles in Oslo Diamond League
-
Duplantis dominates pole vault at Oslo Diamond League
-
Tottenham hire Brentford's Frank as new manager
-
Alfred scorches Diamond League 100m in Oslo
-
Reed makes only fourth albatross in US Open history
-
India plane crash: What we know
-
Cummins says bowler-dominated WTC final still a 'good Test'
-
At least 265 dead in India plane crash, one passenger survives
-
Death toll in S.Africa floods rises to 78
-
Trump boasts troops making Los Angeles 'safe'
-
Trump moves to block California electric cars program
-
Air India crash latest test for new Boeing leadership
-
Trump calls on Israel not to strike as Iran defiant before talks
-
Cummins and Carey shine as Australia remain on top in WTC final despite collapse
-
Los Angeles Grand Slam Track meeting cancelled: sources
-
King Tut gold mask to leave Cairo museum after nearly 100 years
-
California sues Trump for scrapping state's EV rules
-
Spanish PM says knew 'nothing' about corruption case
-
Spaun grabs US Open lead with Scheffler set to attack Oakmont
-
Trump says Israel should not strike Iran, as nuclear deal 'close'
-
Sane joins Galatasaray from Bayern on free transfer
-
Migrants hid in wardrobes to flee N.Ireland unrest: police
-
Pulisic hits back at ex-USA players over absence criticism
-
Fourth policeman killed in clashes with Morales backers in Bolivia
-
South Africa's Rabada and Ngidi spark Australia collapse in WTC final
-
Stewart sprints to Dauphine fifth stage win, Evenepoel holds lead
-
Jury dispute triggers mistrial on Harvey Weinstein rape charge
-
One survivor after London-bound plane with 242 on board crashes in India
-
Heir to an empire, Ferdinand Habsburg seeks new crown at Le Mans
-
Top Spanish ruling party official resigns over corruption case
-
Ukraine's Zelensky hopes to push Trump on US Russia sanctions at G7
-
De Bruyne signs for Napoli after leaving Man City

US limits Covid boosters to over-65s or those at high risk
The United States will limit Covid-19 boosters to people over 65 or those at risk of serious illness, while requiring vaccine makers to run fresh clinical trials before offering shots to younger and healthier individuals, officials said Tuesday.
Writing in the New England Journal of Medicine, the Food and Drug Administration's Vinayak Prasad and Commissioner Martin Makary framed the policy shift as "evidence-based" and would align the United States more closely with guidance in Europe.
But it comes as Health Secretary Robert F. Kennedy Jr., a longtime vaccine skeptic, pushes to remake federal public health policy.
Kennedy previously led a nonprofit that was critical of immunization programs, and during the pandemic petitioned the FDA to revoke Covid vaccine authorizations, citing rare side effects including heart inflammation.
Prasad and Makary praised the initial Covid-19 vaccine rollout as "a major scientific, medical, and regulatory accomplishment," but argued that the benefits of repeated boosters for low-risk individuals are uncertain.
They criticized the US approach of recommending boosters for all adults regardless of age or health status, calling it a "one-size-fits-all" model based on the mistaken belief that Americans couldn't handle more nuanced, risk-based advice.
Rather than building public trust, they wrote, it had backfired -- fueling vaccine hesitancy that has spilled over into skepticism toward childhood shots, including those for measles.
The FDA said it would rely on lab test results to approve boosters for people who are over 65, or over six months old with at least one underlying condition.
But for healthy individuals between six months and 64 years, regulators will now require data from randomized trials.
"We simply don't know whether a healthy 52-year-old woman with a normal BMI (body mass index) who has had Covid-19 three times and has received six previous doses of a Covid-19 vaccine will benefit from the seventh dose," they wrote.
Some infectious disease experts welcomed the shift.
Amesh Adalja of Johns Hopkins University said it matched with the approach taken by other countries in a population that already carries significant immunity.
"For lower-risk individuals, the goal has always been less clear, as protection against infection is transient and they don't have a high risk of severe disease," he told AFP.
But others voiced concern about the practical consequences. Paul Offit, a leading vaccine expert at the Children's Hospital of Philadelphia, said it could limit access for people who still want boosters.
"Any use, say in a healthy 35-year-old, would be considered off-label, and you wonder whether an insurance company would pay for it," he told AFP.
- Not like annual flu shot -
Under the revised framework, companies like Pfizer and Moderna will be encouraged to test updated boosters in adults aged 50 to 64.
These studies should measure whether the vaccines reduce symptomatic infections, hospitalizations and deaths.
Rather than comparing new shots to earlier formulations, Prasad and Makary suggested placebo-controlled trials -- with saline as the comparator -- to better evaluate both benefit and potential side effects.
The proposal, first floated by Kennedy earlier this month, has proved divisive. Critics argue that using a placebo -- when authorized vaccines already exist -- could expose participants to unnecessary harm.
"Imagine if there was a death or two in the placebo group," said Offit. "I don't see how you conscience that."
Supporters of continued Covid-19 boosters often draw parallels to annual flu shots.
But Makary and Prasad pushed back on that comparison, arguing the genetic changes in Covid variants haven’t been significant enough to justify automatically updating the vaccine each year.
The FDA officials also sought to reassure Americans concerned they might lose access to boosters under the new framework.
The Centers for Disease Control and Prevention's (CDC) definition of risk factors is "vast, including obesity and even mental health conditions such as depression," they wrote, noting that between 100 million and 200 million Americans would likely still qualify.
N.Mitchell--AT